Mesoblast Files Annual Report and Shareholder Meeting Notices

Ticker: MEOBF · Form: 6-K · Filed: Oct 18, 2024 · CIK: 1345099

Mesoblast LTD 6-K Filing Summary
FieldDetail
CompanyMesoblast LTD (MEOBF)
Form Type6-K
Filed DateOct 18, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, annual-report, securities-filing

Related Tickers: MESO

TL;DR

MESO filed its annual report and meeting notices on Oct 17, plus share issue/cessation docs on Oct 11. Standard corporate updates.

AI Summary

On October 17, 2024, Mesoblast Limited filed its Annual Report to Shareholders, Notice of Annual General Meeting, and Appendix 4G with the Australian Securities Exchange. Additionally, on October 11, 2024, the company filed announcements regarding the issue and cessation of equity securities (Appendices 3G and 3H). These filings are related to the company's ongoing operations and corporate governance.

Why It Matters

These filings provide shareholders with updates on the company's performance and upcoming governance decisions, impacting investor confidence and strategic direction.

Risk Assessment

Risk Level: low — The filing consists of routine corporate disclosures and does not contain new financial or operational information that would significantly alter risk.

Key Players & Entities

FAQ

What specific documents were filed by Mesoblast Limited on October 17, 2024?

On October 17, 2024, Mesoblast Limited filed its Annual Report to Shareholders, a Notice of Annual General Meeting, and its Appendix 4G and Corporate Governance Statement with the Australian Securities Exchange.

What were the filings made by Mesoblast Limited on October 11, 2024?

On October 11, 2024, Mesoblast Limited filed a new issue announcement (Appendix 3G) regarding the issue, conversion, or payment up of equity securities, and a new issue announcement (Appendix 3H) regarding the cessation of securities.

Where is Mesoblast Limited incorporated?

Mesoblast Limited is incorporated in Australia.

Who is the Chief Executive Officer of Mesoblast Limited?

Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.

What is the Commission File Number for Mesoblast Limited?

The Commission File Number for Mesoblast Limited is 001-37626.

Filing Stats: 403 words · 2 min read · ~1 pages · Grade level 13.5 · Accepted 2024-10-17 21:44:07

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated October 18, 2024 INDEX TO EXHIBITS Item 99.1 Annual Report to Shareholders of Mesoblast Ltd, dated October 17, 2024. 99.2 Notice of Annual General Meeting of Mesoblast Ltd , dated October 17, 2024. 99.3 Appendix 4G and Corporate Governance Statement of Mesoblast Ltd, dated October 17, 2024 99.4 Appendix 3G of Mesoblast Ltd, dated October 11, 2024. 99.5 Appendix 3H of Mesoblast Ltd, dated October 11, 2024.

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing